Advancing Cancer Treatment

Organization Overview

Advancing Cancer Treatment is located in Moultonborough, NH. The organization was established in 2019. According to its NTEE Classification (G12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Advancing Cancer Treatment is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Advancing Cancer Treatment generated $1.5m in total revenue. This organization has experienced exceptional growth, as over the past 3 years, it has increased revenue by an average of 35.4% each year . All expenses for the organization totaled $1.2m during the year ending 12/2021. While expenses have increased by 31.7% per year over the past 3 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Since 2020, Advancing Cancer Treatment has awarded 14 individual grants totaling $1,616,542. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

ACT'S MISSION IS TO MAKE THE WASHINGTON, DC METROPOLITAN AREA A LEADER IN ADVANCING CLINICAL TRIAL ACCRUAL, THUS ACCELERATING IMPROVED CANCER CARE AND TREATMENT.

Describe the Organization's Program Activity:

Part 3 - Line 4a

ACT'S CURRENT FOCUS IS IMPROVING ACCRUAL TO PROSTATE CANCER CLINICAL TRIALS. ACT'S GOAL IS TO CREATE A PROSTATE REGISTRY AIMED AT GETTING A SIGNIFICANT PORTION OF PROSTATE CANCER PATIENTS TO SIGN UP TO PARTICIPATE BY SUBMITTING A SIMPLE SALIVA TEST THAT WILL PROVIDE THEIR GENETIC INFORMATION FOR RESEARCH, AND PROVIDE AN ALERT SERVICE TO THEM IF ANY TREATMENTS OR THERAPIES MATCH THEIR PROFILE AND COULD HELP CHANGE THEIR OUTCOME.


ACT'S CURRENT FOCUS IS IMPROVING ACCRUAL TO PROSTATE CANCER CLINICAL TRIALS. ACT'S GOAL IS TO CREATE A PROSTATE REGISTRY AIMED AT GETTING A SIGNIFICANT PORTION OF PROSTATE CANCER PATIENTS TO SIGN UP TO PARTICIPATE BY SUBMITTING A SIMPLE SALIVA TEST THAT WILL PROVIDE THEIR GENETIC INFORMATION FOR RESEARCH, AND PROVIDE AN ALERT SERVICE TO THEM IF ANY TREATMENTS OR THERAPIES MATCH THEIR PROFILE AND COULD HELP CHANGE THEIR OUTCOME.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Pamela Brown
Vice President, Secretary
$0
David Brown
President, Treasurer
$0
Jenny B Aragon-Ching MD
Director
$0
Donald L Trump MD
Director
$0
Adam R Metwalli MD
Director
$0
Robert Grossman
Director
$0

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$1,500,000
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$1,500,000
Total Program Service Revenue$0
Investment income $77
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $1,500,077

Grants Awarded

Over the last fiscal year, Advancing Cancer Treatment has awarded $308,500 in support to 8 organizations.

Grant RecipientAmount

SIDNEY KIMMEL COMP CANCER CTR

PURPOSE: RESEARCH

$75,000

SIDNEY KIMMEL COMP CANCER CTR

PURPOSE: RESEARCH

$75,000

ZERO-THE END OF PROSTATE CANCER

Org PageRecipient Profile

Alexandria, VA

PURPOSE: RESEARCH

$30,000

ZERO-THE END OF PROSTATE CANCER

Org PageRecipient Profile

Alexandria, VA

PURPOSE: RESEARCH

$30,000

UNIVERSITY OF NC AT CHAPEL HILL

Org PageRecipient Profile

Chapel Hill, NC

PURPOSE: RESEARCH

$28,000

UNIVERSITY OF KANSAS MED CTR

PURPOSE: RESEARCH

$25,000
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 1 grants that Advancing Cancer Treatment has recieved totaling $800,000.

Awarding OrganizationAmount
Fidelity Investments Charitable Gift Fund

Boston, MA

PURPOSE: For grant recipient's exempt purposes

$800,000
View Grant Recipient Profile

Create an account to unlock the data you need.

or